Sirtex in play as founder sells up
A decade after he blocked a takeover bid from an unwanted US interloper, Bruce Gray, who founded cancer treatment group Sirtex Medical, has sold most of his stake in the company, potentially putting it in play.
A block of 7.27 million Sirtex shares was sold at $12 each late on Tuesday, a slight discount to the market price. Sirtex closed Wednesday down 10¢ at $12.35.
The block of shares traded on Tuesday was equal to 12.9 per cent of the company's capital, and raised $87.24 million for Dr Gray.
Dr Gray has been involved in a dispute with the Sirtex board over the way the company has been managed, and he has been gradually selling down his holding over the past six months, taking advantage of an upswing in the share price as it prepares for greater penetration of its cancer treatment in offshore markets.
The sale by Dr Gray opens the door for a possible takeover of the company since the only other large holder, fund manager Hunter Hall has also been selling down its stake. It retains an 18.7 per cent holding in Sirtex.
InvestSMART FORUM: Come and meet the team
We're loading up the van and going on tour from April to June, with events on the NSW central & north coast, the QLD mid-north coast and in Perth, Adelaide, Melbourne, Sydney and Canberra. Come and meet the team and take home simple strategies that you can use to build an investment portfolio to weather any storm. Book your spot here.
Want access to our latest research and new buy ideas?
Start a free 15 day trial and gain access to our research, recommendations and market-beating model portfolios.Sign up for free